Malignant melanoma treated with pembrolizumab during pregnancy: A case report and review of the literature
Open Access
- 24 September 2021
- journal article
- review article
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 15 (5) , 1-5
Abstract
There have been very few reports on the use of immune checkpoint inhibitors for malignant tumors during pregnancy. Herein, the current study reports a case of a patient diagnosed with advanced malignant melanoma who was treated with pembrolizumab during pregnancy. A 40‑year‑old primigravida underwent noninvasive prenatal testing at 10 weeks of gestation, and the result was inconclusive, suggesting the possibility of maternal malignancy. A biopsy of the gluteal mass led to a diagnosis of malignant melanoma, and computed tomography revealed extensive metastases in her lungs and lymph nodes. She had a strong desire to proceed with pregnancy. In consideration of fetal growth and maturation, monotherapy was administered with pembrolizumab from 21 weeks of gestation, aiming for 28 weeks of gestation. The fetus grew well without maternal complications. At 28 weeks of pregnancy, the patient gave birth to a healthy boy by cesarean section. There was no evidence of metastasis in the placenta. The patient received nivolumab‑ipilimumab combination therapy from postpartum day 13, followed by nivolumab monotherapy, and has been alive with controlled disease for 20 months.Keywords
This publication has 18 references indexed in Scilit:
- Case Report of a Pregnancy During Ipilimumab TherapyJournal of Global Oncology, 2018
- Immune checkpoint inhibitors in challenging populationsCancer, 2017
- The accuracy of cell‐free fetal DNA‐based non‐invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta‐analysisBJOG: An International Journal of Obstetrics & Gynaecology, 2016
- An Evaluation of the Impact of PD‐1 Pathway Blockade on Reproductive Safety of Therapeutic PD‐1 InhibitorsBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2016
- Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal MalignanciesJAMA, 2015
- Therapeutic Advances and Treatment Options in Metastatic MelanomaJAMA Oncology, 2015
- Cause-Specific Survival for Women Diagnosed With Cancer During Pregnancy or Lactation: A Registry-Based Cohort StudyJournal of Clinical Oncology, 2009
- Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in uteroCancer, 2006
- Use of chemotherapy during human pregnancyThe Lancet Oncology, 2004
- Metastatic Melanoma in Pregnancy: Risk of Transplacental Metastases in the InfantJournal of Clinical Oncology, 2003